Managing menopausal symptoms in women with a BRCA mutation
OBG Management. 2015 October;27(10):
October 6, 2015|ObGyn
Author and Disclosure Information
Dr. Andrew Kaunitz elaborates on data, presented at NAMS 2015, regarding the use of estrogen and estrogen-progestin in women undergoing risk-reducing gynecologic surgery. He offers his to-the-point advice for clinicians who are treating women with a BRCA mutation.
This audiocast was recorded at the North American Menopause Society Annual Meeting held September 30 to October 3, 2015, in Las Vegas, Nevada
For more on this topic, read Dr. Kaunitz's August 2015 Cases in Menopause article, Is menopausal hormone therapy safe when your patient carries a BRCA mutation?
,